Molecular docking and MD simulation approach to identify potential phytochemical lead molecule against triple negative breast cancer [version 2; peer review: 1 approved, 2 approved with reservations]

Molecular docking and MD simulation approach to identify potential phytochemical lead molecule against triple negative breast cancer [version 2; peer review: 1 approved, 2 approved with reservations]

Background Triple-negative breast cancers (TNBC) are defined as tumors that lack the expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It exhibits unique clinical and pathological features, demonstrates high aggressiveness, and...

Full description

Saved in:
Bibliographic Details
Main Authors: Arabinda Ghosh, M Manikandan, Abhinand PA, Dicky John Davis G, Pranaya Sankaranarayanan
Format: Article
Language:English
Published: F1000 Research Ltd 2025-03-01
Series:F1000Research
Subjects:
Triple Negative Breast Cancer
AR target
Phytochemicals
2–hydroxy naringenin
Virtual screening
Molecular Docking
eng
Online Access:https://f1000research.com/articles/13-1271/v2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items